Pharma Marketing Network

We’ve talked before about how COVID-19 has upended our personal and business lives, and how the pharma industry was able to – impressively – shift gears to meet the challenges the...

  Blockchain technology has become an increasing tool for life science organizations. How is this technology being implemented, and what value does it offer? Join Darshan Kulkarni as he talks with guest...

It’s 2019, your plane is booked, your outfits for the next three days are all planned out and packed away in your suitcase. You have a list of all of the...

Moderator and Panelists: Amy Turnquist, EVP, Digital, eHealthcare Solutions (Moderator) Ryan Billings, U.S. Oncology Digital Marketing & Customer Experience at GSK Desiree Priestley, Director, Patient Support Strategy & Insights at Otsuka...

  The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Marketing and Evolving Patient Centricity - January 27, 2021....

By Stephen Towers, PhD The program for this year’s Biotech Showcase Digital – the leading investor and networking conference for mostly small- and mid-cap biotechnology companies – highlighted several important advances in...

Originally Published by Intouch Group Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Pharma marketers have quickly learned...

The 2021 NextGen Pharma Content, taking place on March 23-24, will bring together content creators, marketers, and communications/PR practitioners to learn how to build trust and earn loyalty with customers to achieve a...

Discover the AI methods & tools set to revolutionize healthcare, medicine & diagnostics, as well as industry applications and key insights at our AI in Healthcare Virtual Summit. This is a 2...

Clinical is under the microscope. As the world focuses its lens on pharma, the opportunity and pressure is there to found a new era of agile, patient-centric clinical trials. Long-standing barriers...